EDT.TO

Spectral Medical Inc.

C$1.00

-2.91%

SectorHealthcareIndustryDiagnostics & ResearchCountryCanadaExchangeTSX · CAD

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

Market CapC$293.6M

Dividend Yield0.00%

AnalystsStrong Buy+215.0% target

Beta0.19

AI summary

Price & performance

1M-9.1%

3M-29.1%

YTD-27.5%

1Y-25.9%

52-week range—

Beta0.19

Full chart and returns against a benchmark

Q-Score

47/ 100

Quality against peers; 50 is the peer median.

Growth65

Risk64

Performance67

Valuation37

Profitability39

Leverage4

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

RevenueC$2.4M+6.8%

Net income-C$47.7M

Net margin—

Historical fundamentals

Valuation

EDT.TOIndustryP/E—44.23P/S135.346.00EV/EBITDA—33.62P/B—5.24PEG—3.91

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Net Margin

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q3 2026	vs a year before
Revenue	C$2.4M	+6.8%	C$275K	—
Net Income	-C$47.7M	—	C$5.1M	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5247

Growth

Industry 5665

Risk

Industry 6464

Performance

Industry 5567

Valuation

Industry 3337

Profitability

Industry 5239

Leverage

Industry 624

Key Metrics

Fundamentals: trailing twelve months to Sep 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.86SM 0.770.09

Market Cap

205.7M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 942.8KSM 673.8K51.1K

Industry Market Share

0.02%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Diagnostics & Research (filled from its sector when there are few), with the median and rank across all 45 in the industry.

Company	Market cap	P/S	P/B	FCF yield	Implied growth	Revenue growth	Op. margin	ROE	Debt/equity
EDT.TOSpectral Medical Inc.	$205.7M	135.3	—	-3.3%	—	-5.1%	-510.1%	—	—
BNRBurning Rock Biotech Limited	$140.2M	1.8	1.8	-3.4%	—	9.2%	-10.2%	-10.3%	0.0
BDSXBiodesix, Inc.	$109.6M	1.0	12.6	-17.4%	—	31.2%	-18.7%	-312.1%	5.8
XGNExagen Inc.	$105.4M	1.5	7.6	-12.4%	—	13.7%	-20.1%	-131.9%	1.7
MYGNMyriad Genetics, Inc.	$542.9M	0.7	2.0	-3.7%	—	-2.6%	-14.3%	-48.0%	0.5
IMDXInsight Molecular Diagnostics Inc.	$70M	41.9	—	-44.3%	—	-60.8%	—	—	—
FLGTFulgent Genetics, Inc.	$689M	2.1	0.7	-0.2%	—	4.7%	-39.2%	-9.2%	0.0
QUCYQuantum Cyber N.V.	$55.2M	102.8	3.4	-29.0%	—	-39.9%	—	-162.8%	0.1
CSTLCastle Biosciences, Inc.	$1B	2.8	2.2	0.4%	40.1%	9.8%	-7.4%	-4.8%	0.0
Industry median		4.1	3.4	0.3%	13.3%	9.2%	-5.3%	0.6%	0.2
EDT.TO percentile		99th	—	37th	—	13th	1st	—	—